The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Differential Effects of the Cyclin-Dependent Kinase Inhibitors p27 Kip1 , p21 Cip1 , and p16 Ink4 on Vascular Smooth Muscle Cell Proliferation
Open accessAbstract
Background —The cyclin-dependent kinase inhibitors (CKIs) have different patterns of expression in vascular diseases. The Kip/Cip CKIs, p27 Kip1 and p21 Cip1 , are upregulated during arterial repair and negatively regulate the growth of vascular smooth muscle cells (VSMCs). In contrast, the Ink CKI, p16 Ink4 , is not expressed in vascular lesions. We hypothesized that a variation in the inactivation of cdk2 and cdk4 during the G 1 phase of the cell cycle by p27 Kip1 , p21 Cip1 , and p16 Ink4 leads to different effects on VSMC growth in vitro and in vivo. Methods and Results —The expression of p27 Kip1 and p21 Cip1 in serum-stimulated VSMCs inactivated cdk2 and cdk4, leading to G 1 growth arrest. p16 Ink4 inhibited cdk4, but not cdk2, kinase activity, producing partial inhibition of VSMC growth in vitro. In an in vivo model of vascular injury, overexpression of p27 Kip1 reduced intimal VSMC proliferation by 52% ( P <0.01) and the intima/media area ratio by 51% ( P <0.005) after vascular injury and gene transfer to pig arteries, when compared with control arteries. p16 Ink4 was a weak inhibitor of intimal VSMC proliferation in injured arteries ( P =NS), and it did not significantly reduce intima/media area ratios ( P =NS), which is consistent with its minor effects on VSMC growth in vitro. Conclusions —p27 Kip1 and p21 Cip1 are potent inhibitors of VSMC growth compared with p16 Ink4 because of their different molecular mechanisms of cyclin-dependent kinase inhibition in the G 1 phase of the cell cycle. These findings have important implications for our understanding of the pathophysiology of vascular proliferative diseases and for the development of molecular therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Cell proliferation in human coronary arteries.
Gordon, D., Reidy, M. A., Benditt, E. P., & Schwartz, S. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4600 · Cited by 532
Cited by
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
Finn, A. V., Nakazawa, G., Joner, M., Kolodgie, F. D., Mont, E. K., Gold, H. K., & Virmani, R. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.144220 · Cited by 900
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
Steffel, J., Lüscher, T. F., & Tanner, F. C. (2006) · Circulation · doi:10.1161/circulationaha.105.567297 · Cited by 456
Self-citationBench to Bedside: The Development of Rapamycin and Its Application to Stent Restenosis
Marx, S. O., & Marks, A. R. (2001) · Circulation · doi:10.1161/01.cir.104.8.852 · Cited by 447
Vascular Smooth Muscle Cell Proliferation in Restenosis
Marx, S. O., Totary-Jain, H., & Marks, A. R. (2011) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.110.957332 · Cited by 354
Metadata
- Authors
- Tanner, F. C., Boehm, M., Akyürek, L. M., San, H., Yang, Z.-Y., Tashiro, J., Nabel, G. J., & Nabel, E. G.
- Venue
- Circulation
- Published
- 2000-05-02
- Volume
- 101
- Issue
- 17
- Pages
- 2022-2025
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1969091160
- Cited by
- 229
- References
- 2
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Effects of the Cyclin-Dependent Kinase Inhibitors p27 Kip1 , p21 Cip1 , and p16 Ink4 on Vascular Smooth Muscle Cell Proliferation. https://app.cochat.ai/papers/10.1161/01.cir.101.17.2022
- The paper
- Tanner, F. C., Boehm, M., Akyürek, L. M., San, H., Yang, Z.-Y., Tashiro, J., Nabel, G. J., & Nabel, E. G. (2000). Differential Effects of the Cyclin-Dependent Kinase Inhibitors p27 Kip1 , p21 Cip1 , and p16 Ink4 on Vascular Smooth Muscle Cell Proliferation. Circulation. https://doi.org/10.1161/01.cir.101.17.2022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.